# Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer

> **NCT01620593** · PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 41 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Placebo
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01620593
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2016-07
- **Final completion:** 2016-09
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2018-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01620593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01620593, "Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01620593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*